ADVERTISEMENT
Josh Bloom, Ph.D. is director of chemical and pharmaceutical science at the American Council on Science and Health.
Lawmakers are right to want to do something that stops the rise in overdose deaths. But adding one category of opioids to the list of Schedule 1 drugs is an exercise in futility.
